Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Valsecchi

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancerG Bolis, G Favalli, S Danese, et al.
The Journal of Clinical Endocrinology and Metabolism|July 21, 2000
Alterations in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with type 2 diabetesP M Piatti, L D Monti, I Zavaroni, et al.
Blood|July 15, 1997
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study GroupA Borkhardt, G Cazzaniga, S Viehmann, et al.
Blood|October 27, 2009
Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic optionsDominique J P M Stumpel, Pauline Schneider, Eddy H J van Roon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 30, 2018
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nervePaola Alberti, Emanuela Rossi, Andreas A Argyriou, et al.
Leukemia|November 13, 2004
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detectionG Gaipa, G Basso, O Maglia, et al.
Blood|October 9, 1998
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcomeM Schrappe, M Aricò, J Harbott, et al.
Blood|December 25, 2009
Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infantsRonald W Stam, Pauline Schneider, Jill A P Hagelstein, et al.
BMC Geriatrics|November 5, 2021
Study protocol: understanding the pathophysiologic mechanisms underlying delirium in older people undergoing hip fracture surgeryR Gamberale, C D'Orlando, S Brunelli, et al.
Blood|December 8, 2009
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemiaRonald W Stam, Monique L Den Boer, Pauline Schneider, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancerG Bolis, G Favalli, S Danese, et al.
The Journal of Clinical Endocrinology and Metabolism|July 21, 2000
Alterations in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with type 2 diabetesP M Piatti, L D Monti, I Zavaroni, et al.
Blood|July 15, 1997
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study GroupA Borkhardt, G Cazzaniga, S Viehmann, et al.
Blood|October 27, 2009
Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic optionsDominique J P M Stumpel, Pauline Schneider, Eddy H J van Roon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 30, 2018
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nervePaola Alberti, Emanuela Rossi, Andreas A Argyriou, et al.
Leukemia|November 13, 2004
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detectionG Gaipa, G Basso, O Maglia, et al.
Blood|October 9, 1998
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcomeM Schrappe, M Aricò, J Harbott, et al.
Blood|December 25, 2009
Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infantsRonald W Stam, Pauline Schneider, Jill A P Hagelstein, et al.
BMC Geriatrics|November 5, 2021
Study protocol: understanding the pathophysiologic mechanisms underlying delirium in older people undergoing hip fracture surgeryR Gamberale, C D'Orlando, S Brunelli, et al.
Blood|December 8, 2009
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemiaRonald W Stam, Monique L Den Boer, Pauline Schneider, et al.
Pageof 11